200 related articles for article (PubMed ID: 30401715)
21. Robust and Facile Automated Radiosynthesis of [
Edwards R; Greenwood HE; McRobbie G; Khan I; Witney TH
Mol Imaging Biol; 2021 Dec; 23(6):854-864. PubMed ID: 34013395
[TBL] [Abstract][Full Text] [Related]
22. PET Imaging of System x
Seo M; Kim Y; Ye BD; Park SH; Kim SY; Jung JH; Hwang SW; Chae SY; Lee DY; Lee SJ; Oh SJ; Kim J; Kim JY; Na SJ; Kim M; Kim SY; Koglin N; Stephens AW; Kweon MN; Moon DH
J Nucl Med; 2022 Oct; 63(10):1586-1591. PubMed ID: 35086893
[TBL] [Abstract][Full Text] [Related]
23. Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
Linher-Melville K; Nashed MG; Ungard RG; Haftchenary S; Rosa DA; Gunning PT; Singh G
PLoS One; 2016; 11(8):e0161202. PubMed ID: 27513743
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography.
Rejc L; Gómez-Vallejo V; Joya A; Arsequell G; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Iglesias L; Capetillo-Zarate E; Ramos-Cabrer P; Martin A; Llop J
Alzheimers Res Ther; 2022 Jun; 14(1):80. PubMed ID: 35676734
[TBL] [Abstract][Full Text] [Related]
25. In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.
Martín A; Vázquez-Villoldo N; Gómez-Vallejo V; Padro D; Soria FN; Szczupak B; Plaza-García S; Arrieta A; Reese T; Llop J; Domercq M; Matute C
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1124-38. PubMed ID: 26659901
[TBL] [Abstract][Full Text] [Related]
26. Characterization of Physiologic (18)F FSPG Uptake in Healthy Volunteers.
Mosci C; Kumar M; Smolarz K; Koglin N; Stephens AW; Schwaiger M; Gambhir SS; Mittra ES
Radiology; 2016 Jun; 279(3):898-905. PubMed ID: 26785040
[TBL] [Abstract][Full Text] [Related]
27. Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
Mittra ES; Koglin N; Mosci C; Kumar M; Hoehne A; Keu KV; Iagaru AH; Mueller A; Berndt M; Bullich S; Friebe M; Schmitt-Willich H; Gekeler V; Fels LM; Bacher-Stier C; Moon DH; Chin FT; Stephens AW; Dinkelborg LM; Gambhir SS
PLoS One; 2016; 11(2):e0148628. PubMed ID: 26890637
[TBL] [Abstract][Full Text] [Related]
28. Exploratory Clinical Investigation of (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate PET of Inflammatory and Infectious Lesions.
Chae SY; Choi CM; Shim TS; Park Y; Park CS; Lee HS; Lee SJ; Oh SJ; Kim SY; Baek S; Koglin N; Stephens AW; Dinkelborg LM; Moon DH
J Nucl Med; 2016 Jan; 57(1):67-9. PubMed ID: 26471694
[TBL] [Abstract][Full Text] [Related]
29. Influx rate of
Pitman KE; Alluri SR; Kristian A; Aarnes EK; Lyng H; Riss PJ; Malinen E
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2190-2198. PubMed ID: 31264167
[TBL] [Abstract][Full Text] [Related]
30. Positron-Emission Tomographic Imaging of a Fluorine 18-Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient-Derived Xenografts.
Laird J; Lok BH; Carney B; Kossatz S; de Stanchina E; Reiner T; Poirier JT; Rudin CM
J Thorac Oncol; 2019 Oct; 14(10):1743-1752. PubMed ID: 31195178
[TBL] [Abstract][Full Text] [Related]
31. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma.
Li Y; Zhang J; Gu J; Hu K; Huang S; Conti PS; Wu H; Chen K
Mol Imaging Biol; 2020 Feb; 22(1):134-143. PubMed ID: 31044341
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of [
Bae SW; Wang J; Georgiou DK; Wen X; Cohen AS; Geng L; Tantawy MN; Manning HC
Tomography; 2023 Feb; 9(2):497-508. PubMed ID: 36961000
[TBL] [Abstract][Full Text] [Related]
33. Prospective comparison of (4S)-4-(3-
Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
[TBL] [Abstract][Full Text] [Related]
34. The Characterization of
Beinat C; Gowrishankar G; Shen B; Alam IS; Robinson E; Haywood T; Patel CB; Azevedo EC; Castillo JB; Ilovich O; Koglin N; Schmitt-Willich H; Berndt M; Mueller A; Zerna M; Srinivasan A; Gambhir SS
J Nucl Med; 2019 Dec; 60(12):1812-1817. PubMed ID: 31171595
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
Chiotellis A; Mu L; Müller A; Selivanova SV; Keller C; Schibli R; Krämer SD; Ametamey SM
Eur J Med Chem; 2013; 70():768-80. PubMed ID: 24239624
[TBL] [Abstract][Full Text] [Related]
36. Is System x
Sharkey AR; Witney TH; Cook GJR
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067277
[TBL] [Abstract][Full Text] [Related]
37. Reactive oxygen species involved in the glutamate toxicity of C6 glioma cells via xc antiporter system.
Mawatari K; Yasui Y; Sugitani K; Takadera T; Kato S
Neuroscience; 1996 Jul; 73(1):201-8. PubMed ID: 8783242
[TBL] [Abstract][Full Text] [Related]
38. The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death.
Banjac A; Perisic T; Sato H; Seiler A; Bannai S; Weiss N; Kölle P; Tschoep K; Issels RD; Daniel PT; Conrad M; Bornkamm GW
Oncogene; 2008 Mar; 27(11):1618-28. PubMed ID: 17828297
[TBL] [Abstract][Full Text] [Related]
39. The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-).
Tsuchihashi K; Okazaki S; Ohmura M; Ishikawa M; Sampetrean O; Onishi N; Wakimoto H; Yoshikawa M; Seishima R; Iwasaki Y; Morikawa T; Abe S; Takao A; Shimizu M; Masuko T; Nagane M; Furnari FB; Akiyama T; Suematsu M; Baba E; Akashi K; Saya H; Nagano O
Cancer Res; 2016 May; 76(10):2954-63. PubMed ID: 26980765
[TBL] [Abstract][Full Text] [Related]
40. Simplified and highly-reliable automated production of [
Lin M; Ta RT; Manning HC
EJNMMI Radiopharm Chem; 2023 Jul; 8(1):15. PubMed ID: 37486582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
